Emerging Infectious Diseases (Jan 2014)

Dynamic Modeling of Cost-effectiveness of Rotavirus Vaccination, Kazakhstan

  • Birgitte Freiesleben de Blasio,
  • Elmira Flem,
  • Renat Latipov,
  • Ajnagul Kuatbaeva,
  • Ivar Sønbø Kristiansen

DOI
https://doi.org/10.3201/eid2001.130019
Journal volume & issue
Vol. 20, no. 1
pp. 29 – 37

Abstract

Read online

The government of Kazakhstan, a middle-income country in Central Asia, is considering the introduction of rotavirus vaccination into its national immunization program. We performed a cost-effectiveness analysis of rotavirus vaccination spanning 20 years by using a synthesis of dynamic transmission models accounting for herd protection. We found that a vaccination program with 90% coverage would prevent ≈880 rotavirus deaths and save an average of 54,784 life-years for children <5 years of age. Indirect protection accounted for 40% and 60% reduction in severe and mild rotavirus gastroenteritis, respectively. Cost per life year gained was US $18,044 from a societal perspective and US $23,892 from a health care perspective. Comparing the 2 key parameters of cost-effectiveness, mortality rates and vaccine cost at <US $2.78 per dose, vaccination program costs would be entirely offset. To further evaluate efficacy of a vaccine program, benefits of indirect protection conferred by vaccination warrant further study.

Keywords